It is also possible that inhibition of a tumor–MDSC interaction was interrupted after BRD4 inhibition, as additional tumor-secreted soluble factors, including chemokines (CCL2, CXCL3, and CXCL5), were all reduced after BRD4 inhibition in vitro. Here, CCL2 is linked to neoplasm.